SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " iop " 339 found 🔀 AI-powered Shuffle
Mapping Air Pollution With MAIA Sensors in Addis Ababa
This map of Addis Ababa, the capital of Ethiopia, shows the locations of 10 air sensors that NASA’s Multi-Angle Imager for Aerosols (MAIA) mission is using to
Chuck Stevens named president of RTI Health Solutions
RTI Health Solutions names Chuck Stevens as president, bringing more than 25 years of biopharmaceutical and life sciences leadership experience.
Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection
Mozambique has reached a major milestone in strengthening the regulation of medicines and imported vaccines, with its national regulatory authority recognized by the World Health Organization (WHO) as having a stable, well-functioning and integrated regulatory system.The Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME) has achieved Maturity Level 3 (ML3) for the regulation of medicines and imported vaccines under WHO’s global classification of national regulatory authorities.Mozambique becomes the 10th country in Africa to reach ML3, joining Egypt, Ethiopia, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania and Zimbabwe and marking further momentum in strengthening regulatory systems across the region.For people in Mozambique, stronger regulation means greater assurance that medicines and vaccines are appropriately evaluated for quality, safety and efficacy and monitored throughout their lifecycle. It also strengthens the country’s ability to identify and respond to safety concerns and substandard or falsified products, while supporting timely access to quality-assured health products.“Mozambique’s achievement is the result of sustained investment in regulatory capacity that will deliver crucial benefits for public health,” said Dr Sylvie Briand, WHO Chief Scientist and Assistant Director-General a.i. for Health Systems, Access and Data. “Strong regulatory systems protect people, build confidence in health products and help countries respond more effectively to evolving public health needs and challenges. Mozambique’s progress also contributes to advancing regulatory capacity across Africa and promoting more equitable access to safe and quality-assured medicines and vaccines.”Building a stronger regulatory systemMozambique’s achievement follows years of sustained efforts to build the institutions and capabilities needed for effective regulation.WHO worked closely with ANARME throughout this process, assessing the national regulatory system and supporting the authority in addressing identified gaps and strengthening priority areas.WHO evaluates national regulatory systems using its Global Benchmarking Tool (GBT), which assesses the regulatory functions required to ensure the quality, safety and efficacy of medical products. These include registration and marketing authorization, licensing, market surveillance and control, pharmacovigilance, regulatory inspection, laboratory testing and oversight of clinical trials, as applicable. WHO’s maturity levels range from 1 to 4. Reaching ML3 confirms a stable, well-functioning and integrated regulatory system, while ML4 represents an advanced system focused on continuous improvement.Benefits for Mozambique and the African continentAn ML3 regulatory system can support more timely and predictable regulatory decisions, reinforce safety monitoring and help ensure that health products entering and remaining on the market meet appropriate standards.It also creates greater opportunities for regulatory cooperation and reliance – approaches that help authorities make use of the work and decisions of trusted regulators, reduce unnecessary duplication and allocate limited resources more efficiently, while maintaining rigorous standards for quality, safety and efficacy.As the first Portuguese-speaking country in Africa to reach ML3, Mozambique’s experience can also contribute to strengthening regulatory systems and fostering greater cooperation, knowledge sharing and reliance among Portuguese-speaking countries and across the African continent. Its achievement further reinforces a more connected African regulatory ecosystem, providing a solid foundation on which the newly established African Medicines Agency can build to advance regulatory convergence and cooperation across the region.Strengthening confidence in regulatory recognitionMozambique’s achievement comes as WHO strengthens the process through which the performance of national regulatory systems is recognized.The newly established Technical Advisory Group on Regulatory Systems Strengthening (TAG-RSS) brings together independent international experts to advise WHO on whether recommendations concerning regulatory authorities reaching ML3 and ML4 and WHO-Listed Authorities, are supported by the findings of WHO evaluation processes. Its recommendations provide an additional level of independent assurance, strengthening the impartiality, transparency and credibility of WHO’s recognition process.Mozambique is among the first countries to achieve ML3 following consideration and recommendation by the TAG-RSS. As part of the same TAG-RSS process, South Africa was recommended to retain its ML3 status for the regulation of vaccines manufactured, imported or distributed in the country, following an additional WHO assessment. This extends the recognition first granted in 2022 and underscores the sustained performance of the South African Health Products Regulatory Authority (SAHPRA).The two recognitions highlight continued progress in strengthening regulatory systems across Africa, as well as the importance of continued performance, improvement and assessment in sustaining regulatory maturity.WHO will continue working with ANARME and SAHPRA to sustain these gains and support continuous improvement as science, technologies and public health needs evolve.
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
/PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today...
Voyager 2’s three surviving instruments are part of humanity’s only direct scientific presence in interstellar space—and with no approved successor under development, engineers remotely reconfigured the 49-year-old probe’s power system in July 2026, completing a delicate operation across a 39-hour command-and-response delay that should preserve its science for at least another year.
Voyager 2's saved watts preserve magnetic-field, plasma-wave and cosmic-ray measurements from beyond the heliopause, where no approved replacement mission is yet on its way.
Jaafar Jackson says sequel will tell Michael Jackson's story from his point of view
Jaafar Jackson says a sequel to the biopic "Michael" will tell Michael Jackson's story from his point of view, as producers and the estate weigh how to address past controversies.
Opening remarks - The Epicenter: Women’s Global Sports Summit presented by Nike
Mel Auguste — Global VP, Sports Marketing, Nike -- with Lisa Bhathal Merage — Governor, Portland Fire & Thorns – and Alex Bhathal — Executive Chair, RAJ Sports.
Meet the scientists 3D printing corneas to restore people's vision, potentially filling a worldwide shortage of transplantable tissue
Corneal blindness affects millions of people globally, but donor tissue for transplants is in short supply. These researchers believe that 3D bioprinting can help close that gap.
Eritrea’s Buffer Zone Politics from Eastern Sudan to Ethiopia's Tigray
The most consequential development in the Horn of Africa may not be taking place in any of its capitals. It is unfolding instead across a chain of borderlands stretching from the Red Sea through Kassala and further eastern Sudan to South and south-eastern to Ethiopia’s…
'Michael' Remains Atop Weekly U.K. Home Entertainment Sales Chart Through Aug. 19
Lionsgate/Universal’s Michael Jackson biopic Michael continues its Official Film Chart run, spending a fifth non-consecutive week atop the weekly U.K. home entertainment sales chart through Aug. 19. Also making a return at No. 2 in its 10th week on the chart was Amazon MGM Studios’ Project Hail Mary, starring Ryan Gosling as science teacher who … Continue reading "‘Michael’ Remains Atop Weekly U.K. Home Entertainment Sales Chart Through Aug. 19"
'Michael' Remains Atop Weekly U.K. Home Entertainment Sales Chart Through Aug. 19
Lionsgate/Universal’s Michael Jackson music biopic Michael continues its Official Film Chart run, spending a fifth non-consecutive week atop the weekly U.K. home entertainment sales chart through Aug. 19. Also making a return at No. 2 in its 10th week on the chart is Amazon MGM Studios’Project Hail Mary, starring Ryan Gosling as science teacher who … Continue reading "‘Michael’ Remains Atop Weekly U.K. Home Entertainment Sales Chart Through Aug. 19"
Opinion: The science that protects our children doesn't take a summer vacation
Connecticut's own biopharmaceutical community has played an important role in advancing vaccine science.
Stolen, Broken, Destroyed: How Impunity Has Fueled Ongoing Attacks on Health Care in Ethiopia
Attacks on health care have become a major feature of armed conflict in Ethiopia. Attacks and threats to health care infrastructure, supply chains, and the health care workforce continue to be used as a tactic in conflict-affected regions of Ethiopia, including Tigray, Amhara, and Afar.
The COVID-19 vaccine may offer brain cancer patients a surprise benefit
A recent shot of the COVID-19 vaccine doubled survival time in glioblastoma patients who had undergone tumor biopsy or surgery.
Streamline Your Business Diagrams with This Microsoft Visio Deal
Give your business operations a visual upgrade with this discounted lifetime license.
Matthew Rhys felt ‘enlivened’ and ‘crappy’ after losing buzzy biopic role to Edward Norton
Matthew Rhys recently auditioned for a role that ultimately went to Edward Norton and eventually landed the ‘Fight Club’ star an Oscar nomination.
From Tony to Jungle: your complete entertainment guide to the week ahead
Dominic Sessa plays Anthony Bourdain in a fun biopic, and the ever-danceable UK funksters are back with a sun-dappled new album
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned...
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
Here’s what that big hospital at the old Sears site in SLC would look like
New renderings of the planned Intermountain Health hospital at the old Sears site in Salt Lake City are here. What do you think of them?
Post-COVID, audience behavior at live shows seems worse
Texting, talking, and generally ignoring the rest of the crowd, audience members seem to have forgotten that live entertainment is a communal experience.
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
/PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative...
Science funding and unnecessary fear
Letters: Prof Stephen Blundell on the plight of the Rutherford Appleton Laboratory, and Peter Forbes on bacteriophages and AI
UToledo Health Rehab Helps 84-Year-Old Qualify for National Senior Games
Ab Khan rebuilt his strength at UToledo Health's Cardiopulmonary Rehabilitation Clinic and earned a gold medal in power walking at the Ohio Senior Olympics qualifying event.
Michael Jackson’s nephew shares never-before-seen photos from the set of ‘Michael’ (exclusive)
The hit biopic will be available to stream on Starz on Monday.
Movies to help understand the politics of immigration
Explore powerful films that illuminate the challenges of immigration, examining policy impacts and sociopolitical drivers for migration.
AI generates personalized radiopharmaceutical therapy doses in under 23 seconds
The model has the potential to improve upon the one-size-fits-all dosing approach used for most RPT prostate cancer treatments.
Emory biophysicist Shashank Shekhar’s research into tiny cellular force generators nets two major federal awards
Emory assistant professor Shashank Shekhar has been awarded $3.5 million in funding for his innovative research focused on how biochemical interactions influence actin, the vital protein responsible for cell structure and movement.
MrBeast Sales Slow, Angel Stock Falls, MUBI and Neon Look for Hits, and Will an NBA Franchise Set a Sales Record?
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) You probably remember egg prices spiking a few years ago. This led to a lot of debate between the pro-market/pro-competition/antitrust/Neo-Brandesian crowd and the center/center-right/center-left/abundance/libertarian crowd over the cause, whether it was the avian flu outbreak or whether industry consolidation led to price fixing, using avian flu as a convenient cover. Basel Musharbash wrote a whole investigation at BIG looking at it. Well, two years later, we have our answer: it was price fixing. The Justice Department found proof, via emails, of price fixing. Indeed, just the threat of an investigation brought prices down two years ago: I bring this up because at least half a dozen of my favorite political writers and pundits, who were skeptical about price fixing at the time, haven’t written any mea culpas on this issue. It’s really dispiriting and makes it much, much harder to trust their work on other issues. If you take a hard stand on an issue, then you get it wrong, you need to explain how and why you got it wrong. Or update your priors. This is how epistemological bubbles are formed! All of which is to say, it’s time for another installment of “What I Got Right, What I Got Wrong”. Last issue, I mostly focused on the “wrong” side of the equation, so today’s is a bit more balanced, but with one big mea culpa (though I still stand by my original concerns). Let’s dive right in! Subscribe CORRECTION: UFC Didn’t Release Subscriber Data (But Seems to Have Bragged About It Internally) In my analysis of the viewership of UFC Freedom 250, I wrote... “Paramount has also released datecdotes bragging about their subscriber numbers. Earlier this year, they claimed that the first UFC fight on Paramount+ brought in 1 million subscribers.” Well, that datecdote did not come from a PR rep, but from great reporting from James Faris at Business Insider. The actual quote was this: “Paramount’s flagship streaming service generated about a million new subscribers on the day of its first-ever UFC event, Paramount product chief Dane Glasgow told employees in a town hall on Tuesday morning, three staffers who attended the meeting told Business Insider.“ This wasn’t the biggest goof in the world; even Faris emphasized to me that this is more a “clarification” than a correction. Still, it sounds like, internally, the folks at Paramount were very happy about this result—and I’m guessing they were happy with this news getting out—even though the gains didn’t last through the quarter, dropping to 700K adds. RIGHT: MrBeast’s Struggles Continue... I’m very skeptical about MrBeast’s burgeoning media “empire” and, in particular, its $5 billion valuation, as I wrote earlier this year and last year. Sure enough, according to Business Insider, regarding its “booming” consumer products division_:_ “US sales volume grew 13% year-over-year in 2025, following a 33% leap the previous year, according to a presentation deck dated May 2026....A February 2025 investor deck viewed by Business Insider showed Feastables’ net revenue more than doubled in 2024 from 2023, to $215 million, and was forecast to grow 74% in 2025, to $375 million.” [Emphasis mine.] If you told investors that you projected 74% growth but delivered 13%,1 that’s not ideal. But it’s not just MrBeast. Logan Paul and KSI’s Prime had sales drop in half for their energy drinks. It’s one thing to build a successful entertainment company and an entirely different thing to succeed in the heavily-consolidated-but-also-very-competitive consumer packaged goods space! CPGs are dominated by a few firms with very wide moats compared to YouTube, which has few barriers to entry. These businesses require different skill sets and have completely different business environments. WRONG: Does the NBA Have an $8 Billion Bidder? Almost as soon as I published my article about the NBA’s finances, casting skepticism on NBA expansion, I saw this Front Office Sports headline: One group “claims to have already raised $8 billion” for the Vegas expansion team. I mean, wow. That’s just $2 billion less than what the Los Angeles Lakers were valued at when they were sold just last year. And they’re arguably the most popular team in the NBA. (Side note: the new owner is now under an investigation for fraud in how he went about financing the Lakers and the Dodgers purchases.) So much for the “dried up” language I used in that article. (This is why I usually stick to my “Entertainment Nuance Guy” tone in articles...) I went off old information—from April, when I read/heard about the NBA downplaying expansion efforts—instead of doing a quick double-check for new news. That said...if you read the article, the market for Seattle is “slow”, with just one reported bidder. So I wasn’t entirely off. This goof has annoyed me since I first published it, mainly because it undercut that article’s real point, which I stand by: NBA franchises are really overvalued right now. Now, I get why NBA teams are overvalued. When it comes to owning sports teams, it’s basically never wrong to assume that some rich person somewhere will care more about owning a team (or just being part of a group since they’re so expensive) than the actual financials. There are only so many teams to own, and opportunities to buy in preferred markets don’t come along very often. This explains why the teams sell for such high multiples (usually above a 10 to 12.5 revenue multiple, which is very high). You only need one person to overpay! Beyond the ultra-wealthy luxury good explanation, I worry NBA teams are becoming speculative assets. More and more private equity investors are buying into NBA teams. But the value, in owning a team, comes from selling it later, not any meaningful relationship to revenue or profit growth. In other words, the newer NBA owners are increasingly expecting someone later to buy their inflated asset. That’s not sound economics; that’s the “greater fool” theory at work.2 At some point, actually making money has to matter. Especially since revenue growth is now below the growth of the stock market. (And this matters because the NBA doesn’t have easy levers to pull to drastically lower their costs—half of their revenue has to go to players and then you actually have to run a team, including coaching, training, travel, media expenses, and more—or raise revenues aside from one-off expansions in America and overseas.) I just don’t see how investors make their money back buying NBA teams, except for selling at a higher price later on down the line. But if revenue/profit growth continues to slow, at some point, someone will be left holding the bag. RIGHT: Baseball and Basketball are about equally popular. Related to the above, I wanted to cite two quick pieces of evidence for one of my other theories: that the NBA and MLB are about as popular as each other, but the NBA gets much, much better media coverage. One YouGov survey has that fans prefer basketball to baseball by 52% to 48%, which I’m guessing is within the margin of error for that poll. That’s virtually even, meaning they’re about the same popularity. Over on NBC, a recent Red Sox-Yankees game averaged 4 million viewers, higher than Sunday Night Basketball’s average of 3.4 million on the same network. A Yankees-Dodgers game averaged 3.9 million two weeks ago. Not every game averages this much, but it shows you that baseball isn’t far off from basketball, depending on the matchup. Altogether, the NBA is just slightly more popular than baseball, but NBC is paying MLB a fraction of what they pay the NBA, a point I’ve made before. RIGHT: Angel, MUBI and Neon Updates... I’ve long been skeptical about many of Hollywood’s buzziest startups/smaller indie studios. It’s not that they don’t make great movies—films like Anora and Everything Everywhere All at Once are amazing—or that they’re not (rightfully) pushing the majors to make better films, but...they get a ton of hype, and that hype often doesn’t live up to the reality or difficulty in scaling up. Starting with MUBI, well, The Wall Street Journal wrote a feature on MUBI’s struggles last April, best summarized by the subheader “After Sequoia valued Mubi at $1 billion, a left-wing revolt sent the indie film company into a tailspin”. MUBI lost $7.3 million on $200 million in revenue in Q4 2025, but reportedly hit a record 1.7 million subscribers at the end of Q1. As for Neon, Department M purchased a “significant stake” in the company earlier this year. How much is that “stake” worth? According to Deadline, “No financial figures for the Neon-Department M deal were disclosed.” So...that’s not great! If it was a big valuation, we’d hear about. Also, I found this curious: “Both Neon and Department M already have separate partnerships with Qatar. The Qatar Film Committee has a slate deal in place with the former, and a biopic production pact with the latter.” Color me skeptical about much Middle Eastern investment dollars. See: LIV Golf. Finally, as for Angel (formerly Angel Studios), their stock very, very slightly popped last month after Young Washington ($20 million budget) which made $45 million in the US, but their stock is still way down from its opening. Smaller Updates RIGHT: The WGA should focus on antitrust concerns! I’ve been on this for years. Post-WGA/AMTPT deal in 2023, I wrote an article for the Ankler calling on the WGA to focus and organize against industry consolidation. Sure enough, the WGA filed a lawsuit against the Paramount-WBD merger, and people are organizing around this issue now. I wish this energy had coalesced earlier (specifically to lobby Washington much earlier), but better late than never! WRONG: Actually, the chip shortage might be due to market manipulation. In my last “Long Reads for the Long Summer” article, I shared an article about how LLMs are causing memory chip prices to spike, which will make all electronics more expensive. Well, turns out, three RAM manufacturers control 90% of the market, and now a private lawsuit accuses them of price-fixing. So yeah. WRONG/UPDATE: The Odyssey will hold! Two weeks ago, I wrote, “As of this moment, we haven’t had a super-blockbuster, though The Odyssey, Spider-Man: Brand New Day and Avengers: Doomsday could all cross the $500 million mark. (At this point, The Odyssey would need a very strong hold to get there.)” Well, it’s safe to say it’s going to have that hold! It only dropped 30% in weekend two and IMAX screenings are sold out all month. Spider-Man: Brand New Day is also off to a great start. RIGHT: People are rushing to get shows out yearly. I’ve long been bullish on yearly, weekly-released shows, and Leslie Goldberg at The Ankler wrote about how many people in town are now listening. WRONG: Mark Carney reverses Canada’s stance on homegrown production. After writing about Canada installing domestic production quotas, Canada has backed off. WRONG: I don’t trust Spider-Man: Brand New Day’s online “views”. When I originally wrote about the latest Spider-Man film’s record-breaking trailer, I thought this was just YouTube views, but after watching this Corridor Crew video and doing more research, well, it’s all social views of the trailer globally. Really? That stat includes TikTok, Reels and YouTube Shorts views. Basically, I don’t trust it anymore. (This film will probably set record, but I trust the pre-sales data more.) RIGHT: Celebrity Production companies are still struggling. I’ve written about this for years, but the company that I didn’t track was Kevin Hart’s HartBeat, which was valued at $650 million but is struggling now and might just end soon, especially after Kevin Hart pulled his endorsement deals. And Bad Robot is moving to NYC. CORRECTION: SpongeBob is a “second run” title. In my 2025 recap article, I had _SpongeBob SquarePants_labelled as a “library” title, when it is still a “second run” show, with new episodes still coming out on Nickelodeon. CORRECTION: In my last “What I Got Right, What I Got Wrong” update, I offered a correction from Doug Creutz and misspelled TD Cowen. Thanks, Grammarly! 1 Though he could have increased prices to make up for the gap, he couldn’t have increased them that much. 2 There’s a theory, which I think that Daryl Morey created and Bill Simmons popularized, that, to be successful building your team, you only need a handful of bad GMs in the league to take advantage of. To be clear, Daryl Morey’s theory was also for signing bad contracts, that you could always get out of bad contracts. Basically, there’s always someone who will make a bad trade. It’s not the same exact thing, but similar enough to the Greater Fool Theory that I really like it.
Emory biophysicist Shashank Shekar’s research into tiny cellular force generators nets two major federal awards
Emory assistant professor Shashank Shekhar has been awarded $3.5 million in funding for his innovative research focused on how biochemical interactions influence actin, the vital protein responsible for cell structure and movement.
Ocular Therapeutix Reports Second Quarter Revenue, Provides Business Highlights
BEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company in the retina space, has reported financial results for the second quarter ended June 30, 2026, and provided recent business highlights. Total net revenue was $13.5 million for the second quarter of 2026, flat as compared with the same period in 2025. The company also reported a net loss of $78.8 million for the quarter, compared with a net loss of $67.8 million for the comparable quarter of 2025.
An Interview with Planetary Politics Director at New America Heela Rasool-Ayub
Heela Rasool-Ayub is director of the Planetary Politics initiative at New America. Before joining us for “Can the Energy Crisis Finally Unite Us?,” co-presented by Thomas Mann House and Zócalo Public Square in partnership with ASU Global Futures Laboratory and the Palisadian-Post, she joined us for a chat about economist Joseph Stiglitz, Afghan food, and the highlands of Ethiopia.
How scientists are trying to repair the body from within: Regenerative medicine and anti-aging
At Scripps Research and its drug discovery arm, the Calibr-Skaggs Institute for Innovative Medicines, scientists are developing regenerative medicine therapies designed to help the body repair itself from within. Unlike traditional medicines that primarily manage symptoms or slow disease progression, regenerative medicine aims to restore damaged tissues and rebuild function lost to aging and disease. Researchers are advancing programs focused on the heart, lungs, digestive tract and eyes, including investigational therapies for heart failure, idiopathic pulmonary fibrosis, inflammatory bowel disease, age-related macular degeneration and other chronic conditions that become more common as we age. Learn how scientists are activating the body’s natural repair mechanisms to explore a future where medicine may not only treat disease, but help reverse its damage.
Liberal court stuns with ruling that hands Trump major immigration win
A liberal-leaning First Circuit panel reversed two district court orders blocking Trump's TPS termination for South Sudan and Ethiopia migrants.
How scholarly publishers are safeguarding trust in science
Antonia Seymour of IOP Publishing is our podcast guest
Richard Pryor Movie Based On Elizabeth Stordeur Pryor Memoir In Works
A Richard Pryor biopic, adapted from the famed comic's daughter’s new memoir 'Something We Said,' is in development, Deadline can report exclusively.
Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
Clock is ticking on Colorado’s new AI rules
By Aashis Luitel On Jan. 1, organizations using covered automated systems must begin complying with Senate Bill 26-189, Colorado’s new Automated Decision-Making Technology Act. They can identify those systems and start building the processes the statute clearly requires. What they cannot do is confidently finalize two key pieces: the disclosures consumers must receive after an […]
Amendment 68: New Opportunity: D.8 Habitable Worlds Observatory Precursor Science Investigations
The Habitable Worlds Observatory (HWO) is a large-aperture ultraviolet/visible/near-infrared observatory concept recommended by the National Academies of
How financial stress can affect the brain over the long term
People who experienced persistent financial struggles were slower to process information and showed memory recall decline by middle age.
Florida State Signs FCS All American CJ Richard Jr
Mike Norvell bolsters a depleted secondary with the ball-hawking Illinois State transfer. The Freshman All-American arrives in Tallahassee ready to anchor a defensive unit desperate for playmakers.
Michelle Yeoh wants to play Yoko Ono in a biopic
Michelle Yeoh revealed that she wants to play Yoko Ono in a biopic when she and her ‘Blade Runner 2099’ costar Hunter Schafer stopped by EW’s 2026 San Diego Comic-Con studio.
Studio 13 Live entertainment headlines with Jodi and Bender from Mornings on 95.7 The Jet
Studio 13 Live host Mireya Garcia talks with Jodi and Bender from Mornings on 95.7 The Jet about all things entertainment—from a "13 Going on 30" reboot, to talks of a Snoop Dogg biopic, they discuss all the top entertainment headlines.
Watch Manycore Tech CEO on Business and AI Strategy
Victor Huang, Co-founder and Chairman at Manycore Tech, discusses the company's business strategy and AI priorities as it unveils its upgrade for its AI video creation agent, LuxReal. He speaks with Minmin Low on Bloomberg: The China Show.
Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026
Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026
Scientists discovered a plastic-eating fungus in the Amazon rainforest that survives without oxygen and could one day help tackle landfill waste worldwide
Deep within the Ecuadorian Amazon rainforest, scientists discovered a fungus with an extraordinary ability that could offer new clues in the fight against plastic pollution. Known as Pestalotiopsis microspora, the fungus can break down polyester polyurethane, a widely used type of plastic, and use it as a source of carbon.
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing innovative...
Home Entertainment Slate for July 14 Includes 'Michael,' 'Obsession,' 'The Mummy' on Disc, 'Backrooms,' 'The Breadwinner' Digitally
Home Entertainment new releases for July 14 include Michael, Obsession, Lee Cronin’s The Mummy and Normal on Blu-ray, while Backrooms and The Breadwinner become available digitally. The hit music biopic Michael will be available on DVD, Blu-ray and 4K Ultra HD disc July 14 from Lionsgate. The 4K Ultra HD combo pack with regular Blu-ray Disc and … Continue reading "Home Entertainment Slate for July 14 Includes ‘Michael,’ ‘Obsession,’ ‘The Mummy’ on Disc, ‘Backrooms,’ ‘The Breadwinner’ Digitally"
Anthropic's Claude Science could disrupt Kendall Square and biopharma
Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts biomedical ecosystem.
Scientists finally solved the mystery of Earth's greatest mass extinction
Why do beaches today have seashells from clams and snails instead of brachiopods? A new study suggests the answer lies in Earth's greatest mass extinction, when warming oceans and falling oxygen levels wiped out animals that couldn't adapt. Species with body plans and metabolisms better suited to the changing conditions survived and went on to dominate the seas, offering a glimpse of how modern marine life could respond to climate change.
A Japanese Hi-Fi Specialist Just Gave Audiophiles a New Reason to Get Excited
The brand is calling these open-back monitors one of its "most ambitious headphone projects to date."
These stunning luxury audiophile headphones just hit a new lowest price, and I’m stunned by the £220 discount
The old but gold Bowers & Wilkins Px8 offers style and substance
Harvard Kennedy School names Betsy Fischer Martin as director of the Institute of Politics
Harvard Kennedy School today named Betsy Fischer Martin as the next director of the Institute of Politics (IOP). She will begin her tenure in mid-August, succeeding interim co-directors Beth Myers and Ned Price, who have led the IOP since December 2025.
The Politics of Policy Formation and Advancing Ethiopia's Place in European Policy Making
The Politics of Policy Formation and Advancing Ethiopia's Place in European Policy MakingDownload
THE MAGIC OF SCIENCE | Texas A&M University Chemistry Road Show lights up the Expo Center with chemistry…not magic!
The Rusk County Library’s Summer Reading Program offered local lectiophiles (lovers of reading) a magical morning filled with ear-piercing explosions, dancing rainbow-colored flames, shattering roses, burning dollar bills that never […]
NASA celebrates Fourth of July with some cosmic fireworks
The release also includes new sonifications of red, white, and blue nebulae and galaxies.
Helio and You: Heliophysics as an American Endeavor
Heliophysics is an important cornerstone of the history of astronomy, and many of the pioneers in this field have been American. This article examines a bit of this history in depth.
World Cup 2026: Netherlands 1-1 Morocco (2-3 on penalties) - Mohamed Ouahbi's side set up last-16 clash with Canada
Match report as Morocco beat Netherlands to reach the World Cup last 16; Cody Gakpo had given Netherlands the lead but Issa Diops stoppage-time header sent the tie to extra time and penalties; Morocco triumphed in a dramatic shootout to set up a last-16 clash with co-hosts Canada
Former ‘Meet the Press’ Executive Producer Betsy Fischer Martin to Lead Harvard IOP | News
Former ‘Meet the Press’ Executive Producer Betsy Fischer Martin to Lead Harvard IOP | News | The Harvard Crimson
Life Science Reagent Market Forecast Points Higher Toward 2035, Driven by Biopharma Scale-Up and Cell Therapy Expansion
World life science reagent market forecast 2026-2035: CAGR 6-8%, index 2035=185. Bioprocessing, cell therapy, and QC drive growth. Key players: Thermo Fisher, Merck, Danaher.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Why the Madonna biopic starring Julia Garner isn't happening after all
Through the process of writing the script, Madonna was bitten by the memoir bug, and she channeled that energy into her forthcoming album "Confessions on a Dance Floor: Part II," which drops July 3.
Amazon no longer releasing Sam Altman biopic 'Artificial' starring Andrew Garfield
Amazon announced that it will no longer release Luca Guadagnino's Sam Altman biopic 'Artificial' starring Andrew Garfield. The news comes four months after OpenAI announced a strategic partnership with Amazon.
The NTS Radio Player brings the best of internet radio to your hi-fi
To hell with algorithms, let a human DJ take the wheel.
Merchants of Doubt and the attacks on Extreme Event Attribution science
Last week, I attended a meeting at Columbia University on attribution science and climate law, hosted by the Sabin Center. It was a fantastic event, bringing together scientists and legal experts working at the intersection of extreme event attribution and climate law. Subscribe For those unfamiliar with it, extreme event attribution attempts to quantify the contribution of climate change to an extreme event. For example, several groups analyzed the impact of climate change on Hurricane Harvey’s enormous rainfall totals over Houston, Texas and they found that climate change increased rainfall by 15 to 38%. One thing that came up again and again was how terrified fossil-fuel interests are of extreme event attribution science. They are acutely aware that this research could land them in court. And losing those cases would leave them legally liable for billions of dollars in climate damages. Because the legal stakes are so high, the blowback has turned ugly. I spoke with several scientists at the meeting who are facing ongoing harassment over their work. This blowback is a coordinated campaign to make the entire field look suspect. The goal is to create the impression that attribution science is too uncertain, too political, or too conflicted to be useful in court or in public policy. The strategy is not based on actual science or evidence of misconduct, but on the generation of doubt. The new Merchants of Doubt We’ve seen this before. In fact, not that long ago: We only have to go back a year to the Department of Energy (DOE) Climate Working Group (CWG) report to see an example of using doubt as the tool to push back against well-established science. This strategy is laid out in an email from a member of the CWG, Dr. Roy Spencer, that was released during litigation over the Climate Working Group process. The key quote is: About all I can hope is that what we write will provide sufficient “reasonable scientific doubt” regarding the science claims in the 2009 TSD [technical support document], based upon almost 2 decades of new science, to call into question the original reasoning for the EPA Administrator’s decision that CO2 presents a threat to human health and welfare. This statement is strong evidence that at least some members of the committee were working to support a particular policy outcome: revoking the Endangerment Finding. The email also explains how they planned to do it: by attempting to generate “reasonable doubt”. This is going to be hard, Spencer implies. Despite falsely claiming that “2 decades of new science” weakens the case, Spencer explicitly acknowledges that the actual peer-reviewed science of climate change overwhelmingly rejects his position: But if the science argument is decided upon by a vote, or by the number of published citations, we lose the science argument. We can go back even further: This CWG email shares unmistakable DNA with the infamous 1969 tobacco memo that declared: “Doubt is our product, since it is the best means of competing with the ‘body of fact’ that exists in the mind of the general public. It is also the means of establishing a controversy.” The tobacco memo also acknowledges the limit of this strategy: Like the CWG, they knew the science was not on their side. Share The new new Merchants of Doubt The people attacking the IPCC chapter on extreme event attribution are the newest iteration of the Merchants of Doubt. Their goal, like all Merchants before them, is to introduce doubt into the process. Because the report is not even out yet, they cannot attack its conclusions. So they are attacking the authors instead. Here is a press release from the House Science, Space, and Technology Committee: In the letter, the Chairmen express concerns about potential conflicts of interest involving members of the Attribution Committee, stating that “publicly available information suggests a troubling pattern” in which committee members are affiliated with nonprofits that support climate accountability lawsuits, “raising the appearance of impropriety and member bias.” To be clear, this is just innuendo. There is no actual evidence of bias. And given the robust process that these reports go through, including multiple lines of peer review, it seems very unlikely that significant bias can survive into the report. When the report comes out, critics will have the opportunity to make legitimate criticisms of the report — if any exist. If none do, however, they’ll still make criticisms, but they’ll be bogus, simply designed to generate doubt. We’ll see. A note to the press: Fix your frame To any journalists reading this: The public debate over extreme event attribution science is not going away. The science is simply too dangerous to fossil-fuel interests for them to stop fighting it. You very well might be assigned to write an article about this area of research in the future. When you do, do not automatically adopt the framing that climate misinformers want you to use. They want you to frame the story around questions like: Are climate scientists trying to put their thumb on the scale to achieve a predetermined, politically motivated result? Are climate scientists improperly letting their politics invade the science of the IPCC? That frame is a trap. Instead, you need to view this through the historical lens of the Merchants of Doubt. How does the ecosystem of doubt operate? Who funds it? What methods do they use to misrepresent science and slime researchers? What scientific results are they trying to keep people from understanding are legitimate? Ultimately, you instead need to focus your article on the generation of doubt as a way to maintain the fossil fuel industry’s social and legal license to keep burning oil, gas, and coal. If you treat the misinformers’ frame as a legitimate, good-faith scientific critique, you are helping them produce doubt. Don’t do it. Don’t be a Merchant of Doubt. Thanks for reading The Climate Brink! Subscribe for free to receive new posts and support our work. Subscribe other stuff The Staying Curious Substack has an interesting post about the different flavors of climate sensitivity. This is crucial information if you want to understand how scientists think about how much warming the Earth will experience. I’d be grateful if you could hit the like button ❤️ below! It helps more people discover these ideas and lets me know what’s connecting with readers.
Katie Thurston Delays Biopsy, New Treatment for Stage 4 Breast Cancer for 'Mental Health Reasons’: ‘I Need a Break’
Katie Thurston has been open about her fear of needles and the emotional toll of her stage 4 breast cancer journey. The ‘Bachelorette’ alum said she’s now pushing back a biopsy and new treatment to prioritize her mental health.
Jay Shetty Says His 'Body Couldn't Keep Up with His Vision' Before Prioritizing This One Aspect in His Wellness Routine (Exclusive)
The global bestselling author and podcast host, 38, talks to PEOPLE about his health journey and latest partnership with BIOptimizers.
Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme
Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme
Favorite countries worth visiting, from solo traveler who's been to 50
After traveling to over 50 countries solo, some of my favorites have been places like Bolivia, Ethiopia, South Korea, Uzbekistan, and Mongolia.
Lucy’s hunter revealed: Giant crocodile terrorized early human ancestors
A newly identified crocodile species nicknamed “Lucy’s hunter” prowled Ethiopia’s rivers when Lucy’s species walked the Earth more than 3 million years ago. The giant predator was likely the most dangerous animal in the ecosystem and may have regularly hunted early human relatives.
Juliano Valdi takes us behind-the-scenes of Michael Jackson biopic (exclusive)
'Michael' star Juliano Krue Valdi is sharing happy memories from the set of the Michael Jackson biopic, including hilarious moments with costar Colman Domingo and winning $50 in a bet with director Antoine Fuqua.
Biophysical Society Condemns OMB Proposed Rule to Politicize Science
BETHESDA, MD – The Biophysical Society condemns the Office of Management and Budgets (OMB) Notice of Proposed Rulemaking (NPRM) on Federal Financial Assistance, released Friday, May 29th. The NPRM is a sweeping overhaul of federal rulemaking and oversight, removing individual oversight from federal agencies to promulgate rules and oversee how regulations are implemented and enforced internally.
Human Research, Biotechnology for Advanced Health Fill Station Research Schedule
Wednesday’s science schedule aboard the International Space Station encompassed human research, microbial analysis, and 3D bioprinting to advance health on and off the Earth. The Expedition 74 crew members also worked on spacesuit maintenance and cargo spacecraft duties throughout the day rounding out their shift.
WiiM launches its first ever Dolby Atmos soundbar – and its sights are set on Sonos
“Cinematic immersion and the audiophile-grade music performance"
Ethiopia holds elections with PM Abiy’s party expected to dominate
Voting will not take place in northern Tigray region and some parts of the Amhara region amid insecurity.
Deshaun Watson Debate Gets New Twist From Browns Insider
A Cleveland Browns insider has fired back about the idea of Deshaun Watson sticking around.
MSU Benefitted From Recent Legislative Session
The recently-completed 2026 regular session of the Mississippi Legislature saw encouraging gains for Mississippi State University, the state’s leading research university, as lawmakers invested in the land-grant institution’s core missions and in the university’s world-class faculty and staff. “While the bulk of our operations saw level funding, I’m extremely pleased that the Mississippi Legislature and […]
Fitbit Air Review: Affordable, Minimalist Health Tracking | All Things Mobile
Free family-friendly movies return to Waikiki for ‘Sunset on the Beach’
The event features live entertainment, games, prizes, and a movie under the stars.
Las Vegas Police: Man shot in head during fight inside Boulder Highway business
Las Vegas police are investigating after a man was shot in the head during a fight at a business on Boulder Highway.
Period poverty: A global menstrual health crisis
500 million women lack menstrual health basics. From Gaza to Ethiopia, CARE is turning period poverty into dignity, one community at a time.
Girl Scouts Event Brings Space Science to the Next Generation
In early May 2026, NASA employees, contractors, and volunteers helped to bring Heliophysics to girls of all ages in a fun-filled weekend of hands-on science activities and experiments.
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Deadline Hollywood
'Heated Rivalry' producer Accent Aigu Entertainment has restructured its management team, while also making several hires. Read more below.
Semiconductor decoupling. Powell's politics. Industrializing Ogaden. Free trade and the Magna Carta.
Thank you for opening your Chartbook email. Feliks Topolski, 1907-1989 8th Army’s Front, Italy 1944 Semiconductor decoupling Source: FT One thing that Jerome Powell deeply understood is that chairing the Fed under current conditions is a deeply political job. “Powell has successes and mistakes to his name. But he stands out as having thought more carefully about the Fed’s democratic legitimacy than any chair since Paul Volcker,” said Paul Tucker, a former deputy governor at the Bank of England, referring to the Fed chair who successfully fought the great inflation of the 1970s and early 1980s. … While Powell was at the Treasury in the early 1990s, he watched Alan Greenspan build relationships within the government. That convinced Powell he needed to follow the former Fed chair’s lead and spend more time in Congress than his predecessors Yellen and Bernanke. “The accountability for the Fed runs through Congress,” said Claudia Sahm, a former Fed official who is now chief economist at New Century Advisors. “That’s not just about having people on speed dial — it’s answering questions, explaining policy and getting feedback.” Source: FT Ethiopia’s PM Abiy and Nigerian business tycoon, with Chinese engineering, are driving industrialization in Ogaden/Somali region of Ethiopia. - Michael Masri’s reporting for Africa Report if fascinating. Ethiopia has launched a cluster of large industrial schemes in the Somali region, laying foundation stones for a urea plant and an oil refinery in Gode while opening the first two phases of the Ogaden LNG project. Abiy Ahmed framed the push as part of a broader strategy to link energy, agriculture and industry. “These projects embody more than industrial growth,” he said. “They represent our shared responsibility to harness opportunities, strengthen co-operation and promote peace.” The Gode urea plant, backed by Dangote Group and Ethiopian Investment Holdings (EIH), is designed for 3m tonnes a year. Dangote owns 60%, while EIH holds 40%. Officials say Dangote’s equity totals about $2.5bn, while the state provides land and implementation oversight. Gas from the Calub fields will be piped 108km to the site. Construction is slated for 40 months, with operations targeted for 2028. Ethiopia imports most of its fertiliser, spending more than $1.2bn a year for 1.5m–2m tonnes. Usage was roughly 1.7m tonnes in 2023, almost half of it urea, and demand for 2024–25 is put above 2.4m tonnes. If delivered on time, the Gode plant could cover domestic needs and allow exports to neighbours. Brook Taye, chief executive of EIH, called the venture “a significant milestone in the journey toward industrial self-sufficiency”. Dangote told the groundbreaking crowd that the complex would be integrated with gas supply and a polypropylene unit to support local inputs. He pointed to Ethiopia’s Grand Ethiopian Renaissance Dam (GERD), with a capacity of more than 5,000MW, and noted his group’s cement operations and expansion plans. The Gode refinery is being developed by Golden Concord Group of China. It is designed to process 3.5m tonnes a year of crude and condensate from the Hilala field, with associated storage. Backers say it will ease foreign-exchange pressure from fuel imports and anchor further industrial activity, including a proposed steel smelting site in Dire Dawa. GCL’s chair, Zhu Gongshan, cast the project as “a key step in Ethiopia’s path to energy sovereignty”, underscoring the Beijing–Addis ties. Financing details are still being finalised, but the refinery is central to the government’s energy-security narrative. Source: The Africa Report Dangote’s Ethiopian vision: Dangote began with cement. His crown jewel, Dangote Cement, dominates Nigeria’s market and has 10 operations in other nations in Africa. The formula has been consistent: identify sectors with chronic shortages – cement, fertiliser, sugar – commit massive local investments, and scale up to serve regional demand. Ethiopia was a natural extension of that model. In 2015, Dangote launched the Mugher Cement Plant outside Addis Ababa at a cost of $600m, with an annual capacity of 2.5 million tonnes. The investment gave him a firm foothold in one of Africa’s fastest-growing construction markets. But success came with risks. In May 2018, violent unrest led to the killing of Dangote’s country manager and temporary shutdowns at Mugher. While other investors might have retreated, Dangote doubled down. Today, he is preparing to spend $400m to expand Mugher’s capacity to 5 million tonnes, alongside a new grinding unit near Addis Ababa. Cement is just one market Dangote is targeting. Ethiopia’s enormous state-controlled sugar industry, long plagued by inefficiency and debt, has struggled for years to reform. Its Omo Kuraz Sugar Development Project, touted as one of the continent’s largest initiatives, continues to face delays and mismanagement. … The most ambitious venture of all is the planned fertiliser production complex in Gode, Somali region. Publicised on 28 August 2025, the Dangote Group and Ethiopian Investment Holdings (EIH) deal plans one of the world’s largest single-site urea manufacturing plants. The project costs an estimated $2.5bn and has an estimated capacity of 3 million metric tonnes annually, a rate that would not only render Ethiopia independent, but even a net exporter of fertiliser. EIH, the state wealth fund of Ethiopia, will hold 40%, while 60% is held by Dangote Group. … For Dangote, Ethiopia is a trifecta: Cement demand is projected to grow by 10% annually, its sugar consumption is growing with rapid urbanisation, and fertiliser demand is all but insatiable, given that farming supports the livelihood of 70% of Ethiopians. Source: The Africa Report The stakes for Abiy are high: For Addis Ababa, the $4bn fertiliser project in Ethiopia’s Somali region is no longer simply a manufacturing investment. It is increasingly being framed as a strategic state project tied to food sovereignty, import substitution and the government’s broader attempt to build economic resilience under mounting fiscal pressure. “Becoming self-sufficient in food is our main agenda,” Abiy says during the visit. “Land is needed; we have it. Water is needed; we have it. Human resources are needed; we have it.” The scale is enormous even by African industrial standards. Once operational, the plant is expected to produce three million metric tonnes of urea annually, potentially making it one of the continent’s largest fertiliser complexes. Ethiopian officials say the project now includes a 110km gas pipeline, a 120MW power plant, a polypropylene packaging facility and a two-million-tonne NPK blending plant. For a government grappling with chronic foreign exchange shortages, ballooning import bills and pressure on agricultural productivity, the numbers matter politically as much as they do economically. The decision to anchor the project in Gode is deliberate. Long viewed as peripheral to Ethiopia’s industrial economy, the Somali region is now being repositioned by the federal government as a future irrigation and agro-industrial corridor. Officials argue that the area’s vast land reserves and access to water could eventually support large-scale commercial farming capable of reshaping Ethiopia’s food economy. The government is simultaneously building housing infrastructure for about 5,000 residents near the plant, while officials project broader industrial expansion along the corridor. Abiy goes further, comparing the long-term revenue potential of the Gode development zone with Ethiopia’s flagship state enterprise. “The investments we are making in this Gode area, combined, will generate high revenue for Ethiopia, at par with Ethiopian Airlines,” he says. Source: The Africa Report Feliks Topolski 1907-1982 Topolski’s Chronicle, ‘Nazi Revival’, Vol. 8, Is. 1-2, 1960 HEY READERS, THANK YOU for opening the Chartbook email. I hope it brightens your day. I enjoy putting out the newsletter, but tbh, what keeps this flow going is the generosity of those readers who clicked the subscription button. Photo by Jakub Dziubak on Unsplash If you are persuaded to click, please consider the annual subscription of $50. It is both better value for you and a much better deal for me, as it involves only one credit card charge. Why feed the payments companies if we don’t have to. Subscribe Grim vision of drone warfare by Sylvie Kaufmann For contributing subscribers only. Subscribe The state of the art in Colbert-studies. Jean-Baptiste Colbert was Louis XIV chief minister from 1661 to 1683 and traditionally seen as an architect of absolutism and mercantilism. Alexander Hamilton later cited him as an inspiration in 1782. Now his legacy is disputed. Daniel Dessert, the chief critic, sees Colbert as the orchestrator not so much of an absolutist state as of an elite cabal. Would be great to have a good English-language review of this important debate. Source: lhistoire Didn’t know that the Magna Carta included free trade provisions Fighting for the right to the beach in Oregon in 1967: Source: Research Gate RAF Station – British and Polish Flags, c. 1940-45, The Ingram Collection Feliks Topolski, 1907-1989 ink and wash If you’ve scrolled this far, you know you want to click: Subscribe
Graduate garners Huntington Award to improve maternal health in Ethiopia
Northeastern’s Blen Yohannes received a 2026 Samuel Huntington Public Service Award to help improve maternal health in Ethiopia.
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
Anavex Life Sciences Corp. (“Anavex” or the “Company”)(Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders, today announced it received anexpected delinquency notification letter (the “Notice”) from the Listing QualificationsDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) on May 20, 2026.
Health Care Roundup: Market Talk
Find insight on AstraZeneca, Sino Biopharmaceutical, ConvaTec and more in the latest Market Talks covering the Health Care sector.
Landon Jackson’s new role equates to best-case scenario
The second-year Bills defender now fits into a role best suited for him
‘Michael’ reclaims the top box office spot in its 4th weekend
The Michael Jackson biopic, “Michael,” is reclaiming the top spot in the North American box office. Studio estimates on Sunday show the film earned $26.1 million in its fourth weekend
Stunning fossil discovery in Ethiopia rewrites human origins
A stunning fossil discovery in Ethiopia shows that early Homo and a previously unknown Australopithecus species lived together around 2.6 to 2.8 million years ago. The find overturns the classic “ape-to-human” progression and paints human evolution as a crowded, branching tree with multiple species coexisting. Scientists dated the fossils using volcanic ash deposits and are now investigating what these ancient relatives ate and whether they competed for resources.
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
How a Jim Caviezel film got mixed up in a Brazilian political scandal
American actor Jim Caviezel's upcoming feature "Dark Horse," a biopic about former Brazilian President Jair Bolsonaro, has been billed by a movie industry publication as a thriller about the far-right firebrand's battle "against a corrupt establishment."
American College of Radiology urges FDA to address breast biopsy needle shortages
“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.
Running back revival? Maybe Dolphins were ahead of the curve with De'Von Achane and his contract
TransCelerate Research Examines the Role of Digital Health Technologies in Patient Safety, Published in DIA's Therapeutic Innovation & Regulatory Science
/PRNewswire/ -- TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating...
British scientists among winners of top Spanish award
British chemists David Klenerman and Shankar Balasubramanian joined French biophysicist Pascal Mayer in winning Spain's top science award on Wednesday for DNA sequencing research that helped combat coronavirus.
Precigen Reports First Quarter 2026 Financial Results and Business Updates
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced first quarter 2026 financial results and business updates.
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
/PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative...